Wu Xiaobin sold $164K of ONC
Wu Xiaobin (President and COO) sold 626 shares of BeOne Medicines Ltd. (ONC) at $261.20 ($0.16M total) on 2026-06-11.
How this was made
The 30-second read
Why it matters
This adds a fresh, timestamped data point on insider ownership but does not include new clinical, regulatory, financial, or deal information that would typically reprice the stock.
Market read
Traders may monitor insider activity as a sentiment input, but the filing alone is unlikely to drive a material repricing without other catalysts.
What to watch
The article notes no pre-arranged 10b5-1 plan, which can increase interpretive uncertainty, but the disclosure still lacks any fundamental linkage.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for BeOne Medicines Ltd. (ONC).
Ticker impact
SEC Form 4 shows ONC President/COO Wu Xiaobin sold 626 shares in an open-market transaction on 2026-06-11 at $261.2017.
Likely minimal near-term impact; any effect is more about sentiment than fundamentals.
The filing is a Form 4 insider sale with no 10b5-1 plan stated and no accompanying operational/regulatory catalyst in the text.
Market effects
No sector read-across provided; this is company-specific insider transaction data only.
None indicated.
None indicated.
Counterpoint
Insider sales can be driven by diversification/taxes rather than bearish expectations, especially for small share counts.
Key entities
- issuerBeOne Medicines Ltd.
Subject of the Form 4 insider transaction disclosure.
- insiderWu Xiaobin
President and COO who sold 626 shares of ONC.
